AML - 296
ADAM17-Driven NKG2D Ligand Shedding Defines a Leukemia-Intrinsic Immune Evasion Program That Predicts Venetoclax Resistance and Reveals MEK and PI3K As Therapeutic Vulnerabilities in AML
Abdelrahman Masheh
Poster Presenter: Abdelrahman Masheh